Treatment Patterns and Resource Use After Osimertinib Discontinuation in Patients with EGFR + Metastatic NSCLC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment Patterns and Resource Use After Osimertinib Discontinuation in Patients with EGFR + Metastatic NSCLC

Published:2024-07-30 Issue:3 Volume:12 Page:549-563
ISSN:2366-1070
Container-title:Oncology and Therapy
language:en
Short-container-title:Oncol Ther

Author:

Marrett Elizabeth,Kwong Winghan Jacqueline,Song Jinlin,Manceur Ameur,Sendhill Selvam,Wu Eric

Funder

Daiichi Sankyo, Inc.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40487-024-00292-5.pdf

Reference35 articles.

1. All cancers: World Health Organization; 2020 [December 2020]. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/39-All-cancers-fact-sheet.pdf. Accessed 21 Jun 2024.

2. SEER cancer stat facts: lung and bronchus cancer Bethesda, MD: National Cancer Institute; 2022 [Available from: https://seer.cancer.gov/statfacts/html/lungb.html. Accessed 21 Jun 2024.

3. Lung cancer - non-small cell: statistics: Cancer.Net; 2023 [March 2023]. Available from: https://www.cancer.net/cancer-types/lung-cancer-non-small-cell/statistics. Accessed 21 Jun 2024.

4. Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016;5(3):288–300.

5. Lung cancer - non-small cell: introduction: Cancer.Net; 2021 [November 2021]. Available from: https://www.cancer.net/cancer-types/lung-cancer-non-small-cell/introduction. Accessed 21 Jun 2024.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP